Radiolabeled Antibodies: Introduction and Metal Conjugation Techniques

  • Sally W. Schwarz
  • Michael J. Welch
Part of the Industry-University Cooperative Chemistry Program Symposia book series (IUCC)

Abstract

The use of radiolabeled antibodies in the detection and treatment of cancer has been in practice since the early 1980’s. Radioimmunoimaging is an in vivo diagnostic technique where a radiolabeled antibody is taken up or bound to an antigen in a target tissue. This allows for non-invasive imaging of the antigen containing tissue, using a gamma camera or a positron emission tomograph (PET) scanner, for subsequent therapy or resection of the tissue if necessary. Radioimmunotherapy is the delivery of a therapeutic quantity of a radioisotope to the same antigen containing tissue to ablate or reduce a primary or metastatic carcinoma. This chapter will cover the basic principles of antibodies, subsequent conjugation with bifunctional chelates and radiolabeling for the purpose of radioimmunoimaging or radioimmunotherapy.

Keywords

Myeloma Cell Positron Emission Tomograph Cardiac Myosin Absorb Radiation Dose Cyclic Anhydride 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Z.D. Grossman, S.F. Rosebough. Clinical Radioimmunoimaging. Grune and Sralton, Inc. 1988.Google Scholar
  2. 2.
    C. Milstein, Monoclonal Antibodies, Scientific Am. 243:66 (1980).CrossRefGoogle Scholar
  3. 3.
    M.W. Sundberg, C.F. Meares, D.A. Goodwin, and C.I. Diamanti, Selective binding of metal ions to macromolecules using bifunctional analogs of EDTA, J Med Chem. 17:1304 (1974).PubMedCrossRefGoogle Scholar
  4. 4.
    S.M. Yeh, D.G. Sherman, and C.F. Meares, A new route to “bifunctional” chelating agentsxonversion of amino acids to analogs of ethylenedinitrilotetraacitic acid, J Anal Biochem. 100:152 (1979).CrossRefGoogle Scholar
  5. 5.
    W.C. Eckelman, S.M. Karesh, and R.C. Reba, New compounds: fatty acid and long chain hydrocarbon derivatives containing a strong chelating agent, J Pharm Sci. 64:704 (1975).PubMedCrossRefGoogle Scholar
  6. 6.
    S.M. Karesh, W.C. Eckelman, and R.C. Reba, Biological distribution of chemical analogs of fatty acids and long chain hydrocarbons containing a strong chelating agent. J Pharm Sci. 66:225 (1977).PubMedCrossRefGoogle Scholar
  7. 7.
    G.E. Krejcarek, and K.L. Tucker, Covalent attachment of chelating groups to macromolecules, J Biochem and Biophys Research Comm. 77:581 (1977).CrossRefGoogle Scholar
  8. 8.
    S.J. Wagner, and M.J. Welch, Gallium-68 labeling of albumin and albumin microspheres, J Nucl Med. 20:428 (1978).Google Scholar
  9. 9.
    B.A. Khaw, J.T. Fallon, H.W. Strauss, E. Haber, O.A. Gansow. Myocardial infait imaging of Ab to canine cardiac myosin with In-111 DTPA, Science. 209:295 (1980).PubMedCrossRefGoogle Scholar
  10. 10.
    D.A. Scheinberg, O.A. Gansow, Tumor imaging with radio metal chelate conjugated to Ab, Science. 215:1511 (1982).PubMedCrossRefGoogle Scholar
  11. 11.
    B.A. Khaw, H.W. Strauss, A. Carvalho, E. Locke, H.K. Gold, E. Haber, Technetium-99m labeling of antibodies to cardiac myosin Fab and to human fibrinogen, J Nucl Med 23:1011 (1982).PubMedGoogle Scholar
  12. 12.
    C.H. Paik, P.R. Murphy, W.C. Eckelman, W.A. Volkert, and R.C. Reba, Optimization of the DTPA mixed-anydride reaction with antibodies at low concentration, J Nucl Med 24:932 (1983).PubMedGoogle Scholar
  13. 13.
    D.J. Hnatowich, W.W. Layne, and R.L. Childs, The preparation and labeling of DTPA-Coupled albumin, J Appl Radiat Isot 33:327 (1982).CrossRefGoogle Scholar
  14. 14.
    C.A. Bunton, J.H. Fendler, N.A. Fuller, S. Perry, J. Rocek, The hydrolysis of carboxylic anhydrides. Part VI. Acid hydrolysis of cyclic anhydrides, J Chem Soc London 6174 (1965).Google Scholar
  15. 15.
    C.H. Paik, M.A. Ebbert, P.R. Murphy, C.R. Lassman, R.C. Reba, W.C. Eckelman, K.Y. Pak, J. Powe, Z. Steplewske, and H. Koprowski, Factors influencing DTPA conjugation with antibodies by cyclic DTPA anhydride, J Nucl Med 24:1158 (1983).PubMedGoogle Scholar
  16. 16.
    M.W. Brechbiel, O.A. Gansow, R.W. Atcher, J. Schlom, J. Esteban, D.E. Simpson, and D. Colcher, Synthesis of 1-(p-Isothiocyanatobenzyl) derivatives of DTPA and EDTA. Antibody labeling and tumor-imaging studies, J Inorg Chem 25:2772 (1986).CrossRefGoogle Scholar
  17. 17.
    D.A. Westerberg, P.L. Carney, P.E. Rogers, S.J. Kline, and D.K. Johnson, Synthesis of novel bifunctional chelators and their use in preparing monoclonal antibody conjugates for tumor targeting, J Med Chem 32:236 (1989).PubMedCrossRefGoogle Scholar
  18. 18.
    G.P. Adams, S.J. DeNardo, S.V. Deshpande, G.L. DeNardo, C.F. Meares, Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in mice, J Can Res 49:1707 (1989).Google Scholar
  19. 19.
    C.J. Mathias, Y. Sun, M.J. Welch, M.A. Green, J.A. Thomas, K.R. Wade, and A.E. Martell, Targeting radiopharmaceuticalsxomparitive biodistribution studies of gallium and indium complexes of multidentate ligands, J Radiat Appl Instrum 15:69 (1988).CrossRefGoogle Scholar
  20. 20.
    C.J. Mathias, Y. Sun, J.M. Connett, G.W. Philpott, M.J. Welch, and A.E. Martell, A new bifunctional chelate, BrMe2HBED: An effective conjugate for radiometals and antibodies, Inorg Chem 29:1475 (1990).CrossRefGoogle Scholar
  21. 21.
    C.J. Mathias, Y. Sun, M.J. Welch, J.M. Connett, G.W. Philpott, and A.E. Martell, N, N-Bis(2-hydroxybenzyl)-1-(4-bromoacetamidobenzyl)-1, 2-ethylene-diamine-N, N-diacetic acid: a new bifunctional chelate for radiolabeling antibodies, J Biocon Chem 1:204 (1990).CrossRefGoogle Scholar
  22. 22.
    S.W. Schwarz, C.J. Mathias, J.Y. Sun, W.G. Dilley, S.A. Wells Jr., A.E. Martell, and M J. Welch, Evaluation of two new bifunctional chelates for radiolabeling a parathyroid-specific monoclonal antibody with In-111, In Press.Google Scholar
  23. 23.
    M.K. Moi, C.F. Meares, MJ. McCall, W.C. Cole, and S.J. DeNardo, Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent J Analytic Biochem 148:249 (1985).CrossRefGoogle Scholar
  24. 24.
    M.J. McCall, H. Diril, and C.F. Meares, Simplified method for conjugating macrocyclic bifunctional chelating agents to antibodies via 2-iminothiolane, J Biocon Chem 1:222 (1990).CrossRefGoogle Scholar
  25. 25.
    V.M. Mukkala, H. Mikola, I. Hemmila, The synthesis and use of activated N-Benzyl derivatives of diethylenetriaminetetraacetic acids: alternative reagents for labeleing of antibodies with metal ions. Anal Biochem 176:319 (1989).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Sally W. Schwarz
    • 1
  • Michael J. Welch
    • 1
  1. 1.Mallinckrodt Institute of RadiologyWashington UniversitySt. LouisUSA

Personalised recommendations